Search - tctmd.com

Displaying 621 - 640 of 795

Sort: Relevancy | Date

Presentation SOLACI 2013

Bare-Metal Stents: It Is Impossible to Abandon Them!

Presenter: Conrad Simpfendorfer

July 25, 2013

Presentation SOLACI 2013

Will Polymeric Metal Stents Survive?

Presenter: Ricardo A. Costa

July 25, 2013

Presentation SOLACI 2013

Mechanical Bifurcation Reconstruction with Self-Expanding Stents Versus Metal Distortion with Provisional Stenting and Double Stenting Techniques

Presenter: John Shulze

July 24, 2013

Presentation

Heparin-bonded Covered Stents vs. BMS for Complex Femoro-popliteal Artery Lesions

Presenter: Johannes Lammer

July 16, 2013

Presentation

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Presenter: Jochen W?hrle

July 09, 2013

Presentation

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

Presenter: T. Palmerini

June 04, 2013

Presentation Fellows 2013

Drug-Eluting Stents: Past, Present, and Future

Presenter: Gregg Stone

April 15, 2013

Presentation

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Presenter: Michael D. Dake

April 10, 2013

Presentation

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Presenter: T. Zeller

April 03, 2013

Presentation ACC 2013

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

Presenter: Ian T. Meredith

March 09, 2013

Presentation ACC 2013

One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Presenter: Masahiro Natsuaki

March 09, 2013

Presentation

Randomized Comparison of Sirolimus-eluting (SES) and Everolimus-eluting (EES) Coronary Stents in the Treatment of Total Coronary Occlusions

Presenter: 13956|Raul Moreno

February 24, 2013

Presentation CTO 2013

Case 5: When the Crossover Stent Technique Fails: Converting to Two Stents

Presenter: Andrejs Erglis

February 22, 2013

Presentation

Paclitaxel-Eluting Balloons, Paclitaxel-Eluting Stents, and Balloon Angioplasty in Patients with Restenosis After DES Implantation

Presenter: Robert A. Byrne

February 07, 2013

Presentation TCT 2013

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Two-Year Outcomes Following Implantation of 32mm and 38mm Platinum Chromium Everolimus Eluting Element Stents in Long Coronary Lesions

Presenter: Paul Teirstein, Gregg Stone, Ian Meredith, Robert Feldman, Joseph Dens, Abram Rabinowitz, Christophe Dubois, Dominic Allocco, Keith Dawkins

January 31, 2013

Presentation TCT 2013

Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomized trials versus other limus-eluting stents and an adjusted indirect comparison.

Presenter: Salvatore Cassese, Gjin Ndrepepa, Lamin King, Tomohisa Tada, Massimiliano Fusaro, Adnan Kastrati

January 31, 2013

Presentation TCT 2013

Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry

Presenter: Gill Buchanan, Alaide Chieffo, Chiara Bernelli, Matteo Montorfano, Mauro Carlino, Azeem Latib, Filippo Figini, Irene Franzoni, Santo Ferrarello, Alfonso Ielasi, Francesco Sacco, Massimo Slavich, Alessandro Durante, Alfredo Castelli, Antonio Colombo

January 31, 2013

Presentation TCT 2013

T-stenting with Two Drug-Eluting Stents Versus One Drug-Eluting Stent with Side Branch PTCA: Long-Term Pathological Findings in Bifurcation Lesions

Presenter: Seung-Jin Oh, Armando Tellez, Maxwell Afari, Gerard Conditt, Jenn McGregor, Yanping Cheng, Geng-Hua Yi, Renu Virmani, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Successful EVAR For Short-necked Abdominal Aortic Aneurysms Using Balloon Expandable Stents By Interventional Cardiologists

Presenter: Abhijeet Basoor, Kirit Patel, Abdul Halabi, Nishit Choksi, Thanh Phan, Michele DeGregorio

January 31, 2013

Advertisement

Bare-Metal Stents: It Is Impossible to Abandon Them!

Will Polymeric Metal Stents Survive?

Mechanical Bifurcation Reconstruction with Self-Expanding Stents Versus Metal Distortion with Provisional Stenting and Double Stenting Techniques

Heparin-bonded Covered Stents vs. BMS for Complex Femoro-popliteal Artery Lesions

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

Drug-Eluting Stents: Past, Present, and Future

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Randomized Comparison of Sirolimus-eluting (SES) and Everolimus-eluting (EES) Coronary Stents in the Treatment of Total Coronary Occlusions

Case 5: When the Crossover Stent Technique Fails: Converting to Two Stents

Paclitaxel-Eluting Balloons, Paclitaxel-Eluting Stents, and Balloon Angioplasty in Patients with Restenosis After DES Implantation

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Two-Year Outcomes Following Implantation of 32mm and 38mm Platinum Chromium Everolimus Eluting Element Stents in Long Coronary Lesions

Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomized trials versus other limus-eluting stents and an adjusted indirect comparison.

Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry

T-stenting with Two Drug-Eluting Stents Versus One Drug-Eluting Stent with Side Branch PTCA: Long-Term Pathological Findings in Bifurcation Lesions

Successful EVAR For Short-necked Abdominal Aortic Aneurysms Using Balloon Expandable Stents By Interventional Cardiologists

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content